Cargando…
Establishing a Public Resource for Acceptable Surrogate Endpoints to Support FDA Marketing Applications
Following a comprehensive and coordinated effort between CBER and CDER, FDA established a table of acceptable surrogate endpoints (SEs) to support drug marketing applications. The publicly accessible SE Table was first published in 2018 as a response to the 21st Century Cures Act legislation and is...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894669/ https://www.ncbi.nlm.nih.gov/pubmed/35252258 http://dx.doi.org/10.3389/fmed.2022.820990 |